OBOLENSKOE PHARMACEUTICAL ENTERPRISE, CJSC,   Russia

Tablets of 5 mg and 10 mg.

Tablets, coated with enteric coating, 5 mg.

Film coated tablets, 2.5 mg, 5 mg and 10 mg.

Tablets, 150 mg.

Tablets, film-coated, 1000 mg.

Capsules of prolonged action, 200 mg.

Tablets of prolonged action, film-coated, 1.5 mg.

Capsules, 2.5 mg.

Tablets of 50 mg.

Tablets 200 mg.

Tablets of 6.25 mg, 12.5 mg and 25 mg.

Film-coated tablets, 25 mg, 100 mg and 200 mg.

The tablets covered with a cover, on 10 mg.

Tablets, 1 mg.

Tablets of prolonged action, coated with a coating, 500 mg.

Tablets, film-coated, 250 and 500 mg each.

Capsules 120 mg.

Capsules of 60 mg.

Capsules of 60 mg.

Tablets, film-coated, 10 mg and 20 mg.

Tablets, 7.5 mg and 15 mg.

Tablets of prolonged action, film-coated, 25 mg, 50 mg and 100 mg.

Tablets, film-coated, 2.5 mg.

Capsules, 100 mg and 200 mg.

Capsules 20 mg

Tablets coated with a film coating of 500 mg.

Capsules 30 mg, 40 mg.

By 7, 8, 10, 14, 28 capsules in the contour cell pack of film polyvinylchloride and aluminum foil printed lacquered.

By 56.112 or 224 capsules in a polymer or glass jar.

According to 1, 2, 3, 4, 5, 6, 7, 8 contour mesh packs or 1 bank together with instructions for use are placed in a pack of cardboard.

Tablets, 250 mg.

Tablets, film-coated, 20 mg and 40 mg.

Tablets, film-coated, 5 mg.

Capsules of 50 and 150 mg.

Capsules 25 mg and 50 mg.

Powder for the preparation of a suspension for oral administration [orange, vanilla], 3 g.